The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03713632
Brief Title: Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) (SUNRISE)

First Submitted : October 18, 2018
First Submitted that Met QC Criteria : October 19, 2018
First Posted : October 22, 2018

Results First Submitted : July 12, 2023
Results First Submitted that Met QC Criteria : July 12, 2023
Results First Posted : August 2, 2023

Certification/Extension First Submitted : July 13, 2021
Certification/Extension First Submitted that Met QC Criteria : July 13, 2021
Certification/Extension First Posted : July 16, 2021

Last Update Submitted that Met QC Criteria : October 10, 2023
Last Update Posted : November 1, 2023